eprintid: 10045527 rev_number: 30 eprint_status: archive userid: 608 dir: disk0/10/04/55/27 datestamp: 2018-03-21 11:04:42 lastmod: 2021-12-22 22:30:01 status_changed: 2018-03-21 11:04:42 type: article metadata_visibility: show creators_name: Rydzewska, LHM creators_name: Burdett, S creators_name: Vale, CL creators_name: Parmar, MKB creators_name: Tierney, JF title: Response to letter commenting on published paper: Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis ispublished: pub divisions: UCL divisions: B02 divisions: D65 divisions: J38 note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. date: 2018-05 date_type: published official_url: https://doi.org/10.1016/j.ejca.2018.02.002 oa_status: green full_text_type: other language: eng primo: open primo_central: open_green verified: verified_manual elements_id: 1542592 doi: 10.1016/j.ejca.2018.02.002 lyricists_name: Burdett, Sarah lyricists_name: Parmar, Mahesh lyricists_name: Rydzewska, Larysa lyricists_name: Tierney, Jayne lyricists_name: Vale, Claire lyricists_id: SBURD20 lyricists_id: MKBPA56 lyricists_id: LHMTR57 lyricists_id: JFTIE32 lyricists_id: CVALE61 actors_name: Stacey, Thomas actors_id: TSSTA20 actors_role: owner full_text_status: public publication: European Journal of Cancer volume: 94 pagerange: 218-229 issn: 1879-0852 citation: Rydzewska, LHM; Burdett, S; Vale, CL; Parmar, MKB; Tierney, JF; (2018) Response to letter commenting on published paper: Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. European Journal of Cancer , 94 pp. 218-229. 10.1016/j.ejca.2018.02.002 <https://doi.org/10.1016/j.ejca.2018.02.002>. Green open access document_url: https://discovery.ucl.ac.uk/id/eprint/10045527/1/Burdett%20LetterToEditor_EJC_Re%20ABI_07MAR2018_AcceptedManuscript.pdf